United Asset Strategies’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,564
Closed -$1.68M 248
2024
Q3
$1.68M Buy
15,564
+387
+3% +$42.2K 0.16% 117
2024
Q2
$1.65M Buy
15,177
+788
+5% +$92.9K 0.16% 111
2024
Q1
$1.9M Buy
14,389
+591
+4% +$73.8K 0.19% 100
2023
Q4
$1.68M Sell
13,798
-2,754
-17% -$307K 0.19% 100
2023
Q3
$1.86M Sell
16,552
-691
-4% -$87.8K 0.24% 88
2023
Q2
$2.51M Sell
17,243
-69
-0.4% -$9.38K 0.31% 71
2023
Q1
$2.24M Buy
17,312
+618
+4% +$77.6K 0.3% 74
2022
Q4
$2.13M Buy
16,694
+747
+5% +$86.7K 0.3% 76
2022
Q3
$1.67M Buy
15,947
+189
+1% +$20.7K 0.26% 86
2022
Q2
$1.66M Buy
15,758
+332
+2% +$39.4K 0.24% 83
2022
Q1
$1.97M Buy
15,426
+1,048
+7% +$126K 0.25% 78
2021
Q4
$1.77M Buy
14,378
+832
+6% +$109K 0.21% 86
2021
Q3
$1.93M Buy
13,546
+772
+6% +$114K 0.25% 76
2021
Q2
$1.99M Buy
12,774
+626
+5% +$101K 0.27% 70
2021
Q1
$1.89M Buy
12,148
+1,407
+13% +$218K 0.27% 73
2020
Q4
$1.61M Buy
10,741
+62
+0.6% +$8.76K 0.25% 78
2020
Q3
$1.41M Sell
10,679
-629
-6% -$82.2K 0.26% 76
2020
Q2
$1.31M Sell
11,308
-184
-2% -$21.2K 0.26% 79
2020
Q1
$1.13M Buy
11,492
+684
+6% +$89.7K 0.28% 77
2019
Q4
$1.57M Buy
+10,808
New +$1.49M 0.31% 81

Other funds holding ZBH

United Asset Strategies's ZBH Position: Q4 2024 in Review

United Asset Strategies sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 15,564 shares — an estimated $1.68M sold.

United Asset Strategies first reported a position in ZBH in Q4 2019 and held it in 20 quarters. The position peaked at $2.51M in Q2 2023. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • United Asset Strategies reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • United Asset Strategies sold 15,564 Zimmer Biomet shares in Q4 2024, an estimated $1.68M.
  • United Asset Strategies first reported a position in Zimmer Biomet in Q4 2019 and held it in 20 quarters.
  • United Asset Strategies's Zimmer Biomet position peaked at $2.51M in Q2 2023.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on United Asset Strategies's 13F filing for Q4 2024, filed 22 Jan 2025.